BioLineRx Ltd. Logo

BioLineRx Ltd.

BLRX | TA

Overview

Corporate Details

ISIN(s):
US09071M2052 (+1 more)
LEI:
529900AKIOSC15Y63R18
Country:
Israel
Address:
Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for patients with specific cancers and rare diseases. The company leverages its comprehensive expertise to advance novel drug candidates through the entire development lifecycle, from preclinical research and clinical trials to regulatory approval and marketing. BioLineRx manages its own pipeline of therapies and also serves as a strategic partner for other drug developers, helping to advance promising early-stage compounds. The company's goal is to deliver meaningful and life-changing treatments that address significant unmet medical needs.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for BioLineRx Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 16:01
Earnings Release
Second Quarter 2025 Financial Results and Provides Corporate Update
English 375.7 KB
2025-08-14 16:01
Foreign Filer Report
Second Quarter 2025 Financial Results and Provides Corporate Update
English 36.5 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 397.4 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 36.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 127.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 153.1 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 36.4 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 430.8 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 36.4 KB
2025-05-24 23:14
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 160.1 KB
2025-05-24 23:14
Foreign Filer Report
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 534.4 KB
2025-05-24 23:14
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 100.8 KB
2025-04-14 13:22
Prospectus
PROSPECTUS SUPPLEMENT
English 415.1 KB
2025-04-14 13:22
Prospectus
PROSPECTUS SUPPLEMENT
English 36.2 KB

Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK